XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

NCT00226668 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
120
Enrollment
INDUSTRY
Sponsor class

Stopped Alternate study projected to assess imaging endpoints versus clinical endpoints.

Conditions

Interventions

Sponsor

Celtic Pharma Development Services

Collaborators